Expanded Access Navigator launched by Reagan-Udall Foundation in collaboration with patient advocacy groups, pharmaceutical industry, FDA, and Federal government

• online tool to guide patients, caregiver, physicians, through process for requesting single-patient expanded access for unapproved investigational drugs
• for patient who has serious or immediately life-threatening disease or condition for which there is no FDA-approved treatment
• permits the product’s manufacturer, with FDA authorization, to provide investigational drug for patient
• physician submits Single Patient Expanded Access request

LEARN

Image Credit: Reagan-Udall Foundation for the FDA